Analyte sensors with a sensing surface having small sensing spots

US12029554B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12029554-B2
Application numberUS-202217822505-A
CountryUS
Kind codeB2
Filing dateAug 26, 2022
Priority dateDec 9, 2010
Publication dateJul 9, 2024
Grant dateJul 9, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Embodiments of the present disclosure relate to analyte determining methods and devices (e.g., electrochemical analyte monitoring systems) that have a sensing surface that includes two or more sensing elements disposed laterally to each other, where the sensing surface is on a working electrode of in vivo and/or in vitro analyte sensors, e.g., continuous and/or automatic in vivo monitoring using analyte sensors and/or test strips. Also provided are systems and methods of using the, for example electrochemical, analyte sensors in analyte monitoring.

First claim

Opening claim text (preview).

The invention claimed is: 1. An in vivo analyte sensor for measuring analyte levels in a bodily fluid of a user comprising: a first portion coupled with a sensor control unit, wherein the first portion is positionable above a surface of a skin, a second portion positionable below the surface of the skin, wherein the second portion is in contact with bodily fluid and configured to measure signals indicative of analyte levels in the bodily fluid, wherein the second portion comprises electrodes connected to contact portions positioned on the first portion; wherein the sensor control unit comprises a processor configured to determine data indicative of analyte levels and to transmit the data indicative of analyte levels to a receiver unit according to a Bluetooth communication protocol via a transmitter coupled to the processor, and a power supply for operating the sensor control unit; further wherein the electrodes of the second portion include a first working electrode comprising a first sensing surface having a first array of two or more sensing elements each deposited separately thereon, and a second array of two or more sensing elements each deposited separately on the first array of sensing elements, wherein each sensing element comprises an analyte-responsive enzyme; and a counter electrode; and a second working electrode comprising a second sensing surface disposed thereon, the second sensing surface including two or more discrete sensing elements each deposited separately thereon; wherein the sensor control unit is configured to process factory-determined calibrated measurements that are input or stored in the sensor control unit, such that the sensing elements are thereby factory calibrated, requiring no user calibration or recalibration. 2. The analyte sensor of claim 1 , wherein the sensing elements of the first sensing surface are discontiguous or contiguous. 3. The analyte sensor of claim 1 , wherein the first sensing surface further comprises inter-feature areas between the sensing elements. 4. The analyte sensor of claim 1 , wherein the sensing elements of the first sensing surface have an average diameter ranging from 0.1 μm to 500 μm. 5. The analyte sensor of claim 1 , wherein the sensing elements of the first sensing surface have a volume ranging from 0.01 μL to 1000 μL. 6. The analyte sensor of claim 1 , wherein at least a portion of the analyte sensor is configured to contact a bodily fluid and the sensing elements of the first sensing surface are configured to detect one or more in vivo analytes therein. 7. The analyte sensor of claim 6 , wherein the one or more in vivo analytes comprises glucose. 8. The analyte sensor of claim 1 , wherein the second array of sensing elements is deposited such that each sensing element in the second array is substantially aligned on top of a corresponding sensing element of the first array of sensing elements. 9. The analyte sensor of claim 1 , wherein the first working electrode is disposed upon a first surface of a substrate and the second working electrode is disposed upon an opposing surface of the substrate. 10. The analyte sensor of claim 1 , wherein the sensing elements of the first sensing surface are discontiguous and wherein the sensing elements of the second sensing surface are contiguous. 11. The analyte sensor of claim 1 , wherein the first working electrode is disposed upon a surface of a substrate, a dielectric is disposed upon the first working electrode, and the second working electrode is disposed upon the dielectric. 12. The analyte sensor of claim 1 , wherein the sensing elements of the first sensing surface are contiguous and wherein the sensing elements of the second sensing surface are discontiguous. 13. The analyte sensor of claim 1 , wherein the first working electrode and the second working electrode are disposed upon a surface of a substrate in a co-planar configuration. 14. A method for monitoring a level of an analyte, the method comprising: collecting data from an analyte sensor, the data correlating to a level of an analyte from signals generated by the analyte sensor, wherein the analyte sensor comprises a first portion coupled with a sensor control unit, wherein the first portion is positionable above a surface of a skin, a second portion positionable below the surface of the skin, wherein the second portion is in contact with bodily fluid and configured to measure signals indicative of analyte levels in the bodily fluid, wherein the second portion comprises electrodes connected to contact portions positioned on the first portion; wherein the sensor control unit comprises a processor configured to determine data indicative of analyte levels and to transmit the data indicative of analyte levels to a receiver unit according to a Bluetooth communication protocol via a transmitter coupled to the processor, and a power supply for operating the sensor control unit; further wherein the electrodes of the second portion include a first working electrode comprising a first sensing surface having a first array of two or more sensing elements each deposited separately thereon, and a second array of two or more sensing elements each deposited separately on the first array of sensing elements, wherein each sensing element comprises an analyte-responsive enzyme; and a counter electrode; and a second working electrode comprising a second sensing surface disposed thereon, the second sensing surface including two or more discrete sensing elements each deposited separately thereon; wherein the sensor control unit is configured to process factory-determined calibrated measurements that are input or stored in the sensor control unit, such that the sensing elements are thereby factory calibrated, requiring no user calibration or recalibration. 15. The method of claim 14 , wherein the sensing elements of the first sensing surface are discontiguous or contiguous. 16. The method of claim 14 , wherein the first sensing surface further comprises inter-feature areas between the sensing elements. 17. The method of claim 14 , wherein the sensing elements of the first sensing surface have an average diameter ranging from 0.1 μm to 500 μm. 18. The method of claim 14 , wherein the sensing elements of the first sensing surface have a volume ranging from 0.01 μL to 1000 μL. 19. The method of claim 14 , wherein the second array of sensing elements is deposited such that each sensing element in the second array is substantially aligned on top of a corresponding sensing element of the first array of sensing elements. 20. The method of claim 14 , wherein the first working electrode is disposed upon a first surface of a substrate and the second working electrode is disposed upon an opposing surface of the substrate. 21. The method of claim 14 , wherein the sensing elements of the first sensing surface are discontiguous and wherein the sensing elements of the second sensing surface are contiguous. 22. The method of claim 14 , wherein the first working electrode is disposed upon a surface of a substrate, a dielectric is disposed upon the first working electrode, and the second working electrode is disposed upon the dielectric. 23. The method of claim 14 , wherein the sensing elements of the first sensing surface are contiguous and wherein the sensing elements of the second sensing surface are discontiguous. 24. The method of claim 14 , wherein the first working electr

Assignees

Inventors

Classifications

  • for glucose · CPC title

  • Enzyme electrodes · CPC title

  • A61B5/1473Primary

    invasive, e.g. introduced into the body by a catheter · CPC title

  • using enzyme electrodes, e.g. with immobilised oxidase · CPC title

  • for measuring glucose, e.g. by tissue impedance measurement · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12029554B2 cover?
Embodiments of the present disclosure relate to analyte determining methods and devices (e.g., electrochemical analyte monitoring systems) that have a sensing surface that includes two or more sensing elements disposed laterally to each other, where the sensing surface is on a working electrode of in vivo and/or in vitro analyte sensors, e.g., continuous and/or automatic in vivo monitoring usin…
Who is the assignee on this patent?
Abbott Diabetes Care Inc
What technology area does this patent fall under?
Primary CPC classification A61B5/1473. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).